* Nyxoah SA NYXH.BR reported a quarterly adjusted loss
of 50
cents per share for the quarter ended September 30, lower than
the same quarter last year, when the company reported EPS of -27
cents. The mean expectation of six analysts for the quarter was
for a loss of 47 cents per share. Wall Street expected
results to range from -56 cents to -42 cents per share.
* Revenue rose 29.7% to $1.27 million from a year ago;
analysts
expected $1.38 million.
* Nyxoah SA's reported EPS for the quarter was a loss of 50
cents.
* The company reported a quarterly loss of €17.06 million.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 3.1%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Nyxoah SA is
14.62
This summary was machine generated from LSEG data November 7 at
04:05 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.47 -0.50 Missed
Jun. 30 2024 -0.43
Mar. 31 2024 -0.42 -0.41 Beat
Dec. 31 2023 -0.38 -0.38 Met